Professor Pierre Lemieux is an economist affiliated with the Department of Management Sciences at the University of Quebec in Outaouais. He holds graduate degrees in economics and philosophy. Besides lecturing at a few Canadian universities, he has been a consultant for a number of private and public organizations in the world. The author of many books, published mainly in America and France, he is a regular contributor to Regulation. He also blogs at Econlib. His latest book is What’s Wrong with Protectionism: Answering Common Objections to Free Trade (Rowman & Littlefield, 2018). He lives in Maine.
There are many different concepts of public health, ranging from protection against epidemics of contagious diseases up to social justice.
In the public goods approach, citizens are considered adults, each of whom is capable of determining what is good for himself.
Public health theorists typically ignore that their proposed interventions have costs.
The forthcoming cost-benefit analyses of the FDA’s proposals for nicotine reduction in tobacco and for banning flavors in e-cigarettes must follow standard economic methodology and not assume away part of the consumer surplus.